For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer or the underlying issuer Bioventix (Sedol B4QVDF0 )
of existing shares to which voting rights are
attached: (ii)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the CASTLEFIELD FUND PARTNERS LIMITED
notification obligation: (iii)
4. Full name of shareholder(s) (if different from 3.): (iv)
5. Date of the transaction and date on 9 (th)January 2017
which the threshold is crossed or
reached: (v)
6. Date on which issuer notified: 12 (th)January 2017
7. Threshold(s) that is/are crossed or 5%
reached: (vi, vii)
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type of Situation previous Resulting situation after the triggering transaction
shares if possible using the ISIN CODE to the triggering
transaction
Number Number Number Number of voting % of
of of of shares rights votin
Shares Voting g
Rights right
s (x)
Direct Direct (xi) Indirect (xii) Direct Indirect
GB00B4QVDF07 250,000 250,000 265,000 265,000 5.197%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period (xiv) rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of financial Exercise price Expiration date (xvii) Exercise/ Number of voting rights instrument refers to % of voting rights (xix, xx)
instrument Conversion period (xviii)
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
265,000 5.197%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: (xxi)
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information: Percentage based on Issued Share Capital of 5,098,656
14. Contact name: Richard Vickers
15. Contact telephone number: 0161 233 4890
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in shares (xxii)
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)
Contact address (registered office for legal entities)
Phone number & email
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
Copyright (c) 2017 PR Newswire Association,LLC. All Rights Reserved